For procurement specialists and R&D scientists in the pharmaceutical industry, understanding the market dynamics for essential chemical intermediates is crucial. N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester (CAS 1334513-02-8) is a high-value intermediate, primarily used in the synthesis of antiviral drugs. Its price and availability are influenced by several key factors, making strategic sourcing a critical task.

The cost of N-[(S)-(Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester is directly tied to the complexity of its synthesis and the purity required. As a chiral molecule with a multi-step manufacturing process, including reactions involving fluorinated compounds and phosphinate chemistry, the raw material costs and specialized processing contribute significantly to its price. Manufacturers in China often provide competitive pricing due to economies of scale and optimized production processes, making them a preferred source for many global pharmaceutical companies looking to buy this intermediate.

Availability can fluctuate based on global demand, particularly from the burgeoning antiviral drug sector. Strong demand for downstream products, such as treatments for Hepatitis C, can lead to increased production orders, influencing lead times and ensuring supply stability. It is advisable for pharmaceutical companies to establish strong relationships with reliable manufacturers and suppliers who can guarantee consistent product availability and manage their inventory effectively. Enquiries for quotes should ideally be placed well in advance of immediate needs, especially for large-scale production runs.

When evaluating suppliers for N-[(S)-(Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester, it's essential to consider not only price but also the supplier's capacity, quality assurance systems, and logistical capabilities. A supplier that can provide a detailed Certificate of Analysis, ensure timely delivery, and offer technical support can be invaluable. By understanding these market factors and focusing on building partnerships with trusted manufacturers, procurement teams can secure the necessary quantities of this vital pharmaceutical intermediate at optimal pricing, thereby supporting the uninterrupted progress of their drug development and manufacturing pipelines.